Zala Megyei Szent Rafael Korhaz

At Zala Megyei Szent Rafael Korhaz, cardiovascular research focuses on cardiovascular disease, primary prevention of atherosclerotic cardiovascular disease, and acute myocardial infarction. These studies are designed to evaluate new ways to reduce heart-related risk, improve prevention, and support recovery after major cardiac events.

• Testing therapies aimed at lowering the risk of major cardiovascular events
• Studying treatment options for patients after a heart attack
• Evaluating approaches for prevention in high-risk individuals

This work highlights a strong interest in improving both long-term cardiovascular protection and immediate care for patients with serious heart disease.

Research in eye diseases includes studies of diabetic macular edema, a vision-threatening complication of diabetes. The trials are focused on assessing new treatments that may help protect sight and improve control of retinal swelling.

• Evaluating a new therapy for diabetic eye disease
• Assessing safety and tolerability in patients with retinal complications
• Exploring options that may improve visual outcomes

These studies reflect the site’s involvement in ophthalmic research aimed at preserving vision in people affected by diabetes.

The oncology program at Zala Megyei Szent Rafael Korhaz is active in neoplasm research, including advanced tumors, extensive stage small cell lung cancer, and ER+/HER2- early breast cancer. The trials are centered on improving cancer treatment effectiveness, reducing recurrence, and extending survival.

• Testing new approaches for advanced and hard-to-treat cancers
• Studying therapies for lung cancer and breast cancer
• Evaluating strategies to prevent cancer return after initial treatment

This area shows a broad oncology focus, with research aimed at both advanced disease control and earlier-stage cancer management.

Clinical trials in nutritional and metabolic diseases address obesity and type 2 diabetes. The main purpose is to test therapies that can improve blood sugar control, support weight reduction, and lower the health risks linked to metabolic illness.

• Evaluating treatments for better glucose control in type 2 diabetes
• Studying therapies for obesity in people with additional cardiovascular risk
• Exploring ways to improve overall metabolic health

These trials combine diabetes and weight-management research, reflecting the growing need for integrated care in chronic metabolic conditions.

Research in respiratory tract diseases includes studies of extensive stage small cell lung cancer. The trials are aimed at evaluating whether new treatment strategies can improve survival and support better outcomes in this aggressive cancer.

• Assessing treatment effectiveness in advanced lung cancer
• Studying options that may improve overall survival
• Supporting development of better cancer care for respiratory malignancies

The site’s respiratory research is closely linked with its oncology expertise, especially in difficult-to-treat lung cancer.